Author: Thomas Desautels; Adam Zemla; Edmond Lau; Magdalena Franco; Daniel Faissol
Title: Rapid in silico design of antibodies targeting SARS-CoV-2 using machine learning and supercomputing Document date: 2020_4_10
ID: kg2j0dqy_1
Snippet: Numerous promising therapeutic [1, 2] or vaccine [3, 4] research efforts are underway for COVID-19, yet a therapeutic or vaccine is not currently available. Traditional drug and biologic development are experiment-driven, typically executed via large-scale screening in vitro and in vivo. While traditional approaches have led to many effective and safe therapeutics, they require years to complete and therefore cannot alone be relied upon to suppor.....
Document: Numerous promising therapeutic [1, 2] or vaccine [3, 4] research efforts are underway for COVID-19, yet a therapeutic or vaccine is not currently available. Traditional drug and biologic development are experiment-driven, typically executed via large-scale screening in vitro and in vivo. While traditional approaches have led to many effective and safe therapeutics, they require years to complete and therefore cannot alone be relied upon to support a rapid response to novel pathogens [5] [6] [7] .
Search related documents:
Co phrase search for related documents- large scale and rapid response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- large scale and research effort: 1, 2, 3, 4, 5, 6, 7
- large scale and safe effective therapeutic: 1
- large scale and traditional approach: 1, 2, 3, 4, 5, 6
- large scale and vivo vitro large scale screening: 1, 2
- large scale and year require: 1
- large scale screening and research effort: 1
- large scale screening and vivo vitro large scale screening: 1, 2
- novel pathogen and rapid response: 1, 2, 3, 4, 5
- novel pathogen and traditional approach: 1
- rapid response and research effort: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date